Business & Economy · 1 views
GLP-1 drugs are fueling the rise of the 'big kids' market, one mega restaurant chain says
Diners on GLP-1 drugs are increasingly opting for smaller kids meals, said Cava CEO Brett Schulman.
Source Business Insider AI Summary Updated 1h 21m ago
Business & Economy 
Story intelligence Beta
Freshness Fresh Updated 1h 21m ago
Confidence Limited Single-outlet story
Coverage Single outlet
Views 1 Community interest
Read time 1 min ~16 words
AI Summary
Diners on GLP-1 drugs are increasingly opting for smaller kids meals, said Cava CEO Brett Schulman.
Read full article on BusinessinsiderAI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are used SUPPORT HAPPENINGNOW · Independent AI News Intelligence
Enjoyed this article? Consider supporting HappeningNow to help keep independent AI-powered news analysis moving forward. Your contribution helps cover infrastructure, AI summaries, and continued platform development.
Support HappeningNowMore from Business & Economy
Continue reading recent Business & Economy coverage
- World's largest sovereign wealth fund posts record $184 billion profit as it reveals SpaceX stake for the first timeContinue reading
- Houthi attack kills six in first fatalities in Red Sea in over a year; U.S. strikes container shipContinue reading
- Oil prices rise as Red Sea, Gulf of Oman attacks heighten supply concernsContinue reading